The price you pay for Soliris may depend on factors such as whether you have health insurance. Financial assistance may be available to help you with the cost of Soliris. your treatment plan your ...

CHESHIRE, Conn., Jun 17, 2014 (BUSINESS WIRE) -- Alexion Pharmaceuticals ALXN -0.02% today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to ...

Soliris (eculizumab) is a brand-name drug prescribed for certain autoimmune conditions in adults and some children. A healthcare professional administers Soliris as an IV infusion. The dosage can vary ...

Soliris is widely considered the world’s most expensive drug, at an average annual price of $440,000. It was first approved in 2007 and treats a rare blood disorder that affects only a few thousand ...

Soliris (eculizumab) is a brand-name injection that’s prescribed for certain autoimmune conditions. As with other drugs, Soliris can cause side effects, such as hair loss. Soliris has a boxed warning.

- 98% of adult anti-aquaporin-4 (AQP4) antibody-positive patients treated with SOLIRIS were relapse free compared to 63% receiving placebo at 48 weeks - “We are pleased that the Japanese health ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Alexion announced today that the European Commission (EC) has approved updates to the EU label for the therapeutic indication of Soliris ® (eculizumab) in the ...

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License ...

The Soliris (Eculizumab) Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape. It provides ...

Soliris (eculizumab) is a prescription drug used to treat certain rare autoimmune conditions. It comes as a liquid solution for intravenous infusion by a healthcare professional. The dosage depends on ...